ALIGOS THERAPEUTICS INC (ALGS) Stock Cash Flow
NASDAQ:ALGS - Nasdaq - US01626L2043 - Common Stock - Currency: USD
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -76.95M | -87.68M | -96.05M | -128.33M | -108.54M | |||
| Depreciation Amortization | 1.18M | 1.56M | 2.31M | 3.02M | 2.74M | |||
| Change In Working Capital | -4.86M | -9.53M | -1.55M | -4.65M | 16.06M | |||
| Interest Paid | N/A | N/A | 0.00 | 0.00 | 0.00 | |||
| Taxes Paid | N/A | N/A | 0.00 | N/A | 0.00 | |||
| Other non cash items | -4.37M | 16.65M | 15.90M | 14.30M | 15.48M | |||
| OPERATING CASH FLOW | -85.00M | -79.00M | -79.39M | -115.66M | -74.26M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -111.00K | -19.00K | -940.00K | -890.00K | -2.06M | |||
| Other Investing Activity | -38.15M | 45.00M | -25.35M | 3.91M | 34.82M | |||
| INVESTING CASH FLOW | -38.26M | 44.98M | -26.29M | 3.02M | 32.76M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -46.00K | -96.00K | -60.00K | -80.00K | -60.00K | |||
| Stock Issued/Repurchased | 88.24M | 88.42M | 230.00K | 79.63M | 196.52M | |||
| Other Financing Activity | N/A | N/A | N/A | -880.00K | -4.12M | |||
| FINANCING CASH FLOW | 88.20M | 88.33M | 160.00K | 78.68M | 192.35M | |||
| CHANGE IN CASH | -35.06M | 54.31M | -105.52M | -33.96M | 150.85M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -85.00M | -79.00M | -79.39M | -115.66M | -74.26M | |||
| Capital Expenditure | -111.00K | -19.00K | -940.00K | -890.00K | -2.06M | |||
| FREE CASH FLOW | -85.11M | -79.02M | -80.33M | -116.55M | -76.32M | |||
All data in USD